The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical outcomes and molecular features of lung-specific and liver-specific metastases in pancreatic ductal adenocarcinoma (PDAC).
 
Arsen Osipov
No Relationships to Disclose
 
Edik Matthew Blais
Employment - Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
 
John Davelaar
No Relationships to Disclose
 
Natalie Moshayedi
No Relationships to Disclose
 
Nima Nikravesh
No Relationships to Disclose
 
Gillian Gresham
No Relationships to Disclose
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - Alphamab; Ambrx; AstraZeneca; Biosynergies; Coherent; datarevive; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Merrimack; Mingruizhiyao; NovaGenesis; novarock
Research Funding - Amgen; AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
 
Autumn Jackson McRee
Honoraria - Cor2Ed
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Cor2Ed
 
Jennifer W. Chuy
No Relationships to Disclose
 
Rachna T. Shroff
Consulting or Advisory Role - AstraZeneca; Basilea; Boehringer Ingelheim; Exelixis; Genentech; Helsinn Therapeutics; Incyte; Merck; QED Therapeutics; SERVIER; Taiho Pharmaceutical
Speakers' Bureau - Helsinn Therapeutics; SERVIER
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Immunovaccine; Loxo/Lilly; Merck; Novocure; Nucana; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen; Taiho Pharmaceutical
 
Raymond Couric Wadlow
No Relationships to Disclose
 
Gary Lee Gregory
Employment - Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Patents, Royalties, Other Intellectual Property - Perthera
 
Patricia DeArbeloa
Employment - Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
 
Lynn McCormick Matrisian
Other Relationship - Abbvie (Inst); Amgen Foundation (Inst); AngioDynamics (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Elstar Therapeutics (Inst); ERYTECH Pharma (Inst); FibroGen (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Immunovia (Inst); Interpace Diagnostics (Inst); Ipsen (Inst); Janssen Research & Development (Inst); Johnson & Johnson (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck Sharp & Dohme (Inst); Myriad Genetics (Inst); Novartis (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Takeda (Inst); Tempus (Inst); TriSalus Life Sciences (Inst); TYME (Inst)
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera; Theralink
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Theralink
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Halozyme
Consulting or Advisory Role - AstraZeneca/MedImmune; Foundation Medicine; Merck; Novartis; Perthera; Pfizer
Research Funding - Arcus Biosciences (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
 
Shant Thomassian
No Relationships to Disclose
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; Clinical Congress Consultants; Elsevier; Exelixis; QED Therapeutics
Consulting or Advisory Role - Amgen; Astellas Pharma; Clinical Congress Consultants; Elsevier; Exelixis; QED Therapeutics
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen